Recruiting
Genetic Predisposition to Breast and Ovarian Cancer: Prospective Study of BRCAx Gene Mutation
Cohort of subjects carrying a BRCA gene mutation: genetic predispositions to breast and ovarian cancers
ClinicalTrials.gov IDNCT03667417
PhaseNot Applicable
Enrollment5000
SponsorInstitut Paoli-Calmettes
Age18 Years
SexALL
Conditions studied
Breast Cancers, Ovarian Cancers
About this study
Cohort of subjects carrying a BRCA gene mutation: genetic predispositions to breast and ovarian cancers
Interventions
- Other: Questionnaires — standardized data collection and 10-year prospective follow-up
Primary outcomes
- Incidence of breast and / or ovarian cancer during subject lifetime (10 years)
Eligibility information
1. Woman or man, with or without cancer, carrying a deleterious BRCA1/BRCA2 mutation, aged 18 years and over.
1. Woman with or without breast cancer or ovarian cancer at baseline.
2. Man with or without breast cancer at baseline.
2. Signed consent to participation
3. Affiliation to a social security regimen, or beneficiary of such a regimen.
Exclusion Criteria:
1. A person of legal age subject to a legal protection measure, or unable to express consent.
2. Impossibility to submit to the follow-up of the test for geographical, social or psychological reasons
Study locations
- Institut Paoli-Calmettes, Marseille, 13009 France
Before you participate: Varda Clinical is an independent discovery tool, not the study sponsor or a medical provider. Eligibility can only be determined by the official study team. Discuss potential risks and benefits with a qualified healthcare professional.
Source: ClinicalTrials.gov. Record last refreshed by Varda Clinical: 2026-09-27.